LANSOPRAZOLE ZYDUS FRANCE 15 mg, gastro-resistant capsule 30 capsules
Active ingredients: Lansoprazole
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant capsule30 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LANSOPRAZOLE ZYDUS FRANCE 15 mg, gélule gastro-résistante
- Pharmaceutical form
- gélule gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 30 gélule(s)
- Marketing authorisation holder
- ZYDUS FRANCE
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut etre pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Reflux gastro-oesophagien et oesophagite associée<br>- Ulcère duodénal<br>- Prévention des lésions gastro-duodénales induites par les anti-inflammatoires non stéroidiens ; JOURNAL OFFICIEL ; 18/06/02
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Mar 2014
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63630172CIP72695756CIP133400926957568Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LANSOPRAZOLEgélule | 15 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.